 | Xeris Biopharma Holdings, Inc. | |||
| NMS : XERS || Location: United States | ||||
$1.78+0.02 (+1.14%) |
0.07 M | 1.75 - 1.78 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 8.985 M |
| March 15, 2024 | 9.243 M |
| Feb. 29, 2024 | 9.643 M |
| Feb. 15, 2024 | 9.422 M |
| Jan. 31, 2024 | 9.396 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.10 | -0.10 | 0.00% |
| 09/30/2023 | -0.12 | -0.09 | 23.92% |
| 06/30/2023 | -0.13 | -0.14 | -7.61% |
| 03/31/2023 | -0.17 | -0.12 | 29.78% |
| 12/31/2022 | -0.16 | -0.10 | 37.77% |
XERS Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 140.453M | Shares Float | 134.199M |
| Short Float | 8.985M | Market Cap | 247.20M |
| Institution ownership | 44.67% | Insider ownership | 3.941% |
| Earnings Date | 05/08/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.45 | Forward EPS | -0.22 |